Biblio
Export 160 results:
Author [ Title] Type Year Filters: First Letter Of Title is R [Clear All Filters]
“Rab10 Phosphorylation is a Prominent Pathological Feature in Alzheimer's Disease.”, J Alzheimers Dis, vol. 63, no. 1, pp. 157-165, 2018.
, “Race Differences in the Association Between Sleep Medication Use and Risk of Dementia.”, J Alzheimers Dis, vol. 91, no. 3, pp. 1133-1139, 2022.
, “Race/Ethnic Disparities in Mild Cognitive Impairment and Dementia: The Northern Manhattan Study.”, J Alzheimers Dis, vol. 80, no. 3, pp. 1129-1138, 2021.
, “Race-Related Association between APOE Genotype and Alzheimer's Disease: A Systematic Review and Meta-Analysis.”, J Alzheimers Dis, vol. 83, no. 2, pp. 897-906, 2021.
, “Racial/Ethnic Disparities in Misidentification of Dementia in Medicare Claims: Results from the Washington Heights-Inwood Columbia Aging Project.”, J Alzheimers Dis, vol. 96, no. 1, pp. 359-368, 2023.
, “Radiological-Pathological Correlation in Alzheimer's Disease: Systematic Review of Antemortem Magnetic Resonance Imaging Findings.”, J Alzheimers Dis, vol. 57, no. 2, pp. 575-601, 2017.
, “Radiopharmaceuticals for Assessment of Altered Metabolism and Biometal Fluxes in Brain Aging and Alzheimer's Disease with Positron Emission Tomography.”, J Alzheimers Dis, vol. 59, no. 2, pp. 527-536, 2017.
, “Raman Spectrometric Detection Methods for Early and Non-Invasive Diagnosis of Alzheimer's Disease.”, J Alzheimers Dis, vol. 57, no. 4, pp. 1145-1156, 2017.
, “A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Assessing Safety, Tolerability, and Efficacy of Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's Disease.”, J Alzheimers Dis, vol. 67, no. 2, pp. 555-570, 2019.
, “A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Oral ELND005 (scyllo-Inositol) in Young Adults with Down Syndrome without Dementia.”, J Alzheimers Dis, vol. 58, no. 2, pp. 401-411, 2017.
, “Rapidly Progressive Alzheimer's Disease: Contributions to Clinical-Pathological Definition and Diagnosis.”, J Alzheimers Dis, 2018.
, “Rapidly Progressive Alzheimer's Disease in Two Distinct Autopsy Cohorts.”, J Alzheimers Dis, vol. 64, no. 3, pp. 973-980, 2018.
, “Rapidly Progressive Frontotemporal Dementia Associated with MAPT Mutation G389R.”, J Alzheimers Dis, vol. 55, no. 2, pp. 777-785, 2017.
, “Rare Genetic Variant in SORL1 May Increase Penetrance of Alzheimer's Disease in a Family with Several Generations of APOE-ɛ4 Homozygosity.”, J Alzheimers Dis, vol. 56, no. 1, pp. 63-74, 2017.
, “Rare Variants in PLD3 Increase Risk for Alzheimer's Disease in Han Chinese.”, J Alzheimers Dis, vol. 64, no. 1, pp. 55-59, 2018.
, “Rationale and Design of the Mechanistic Potential of Antihypertensives in Preclinical Alzheimer's (HEART) Trial.”, J Alzheimers Dis, vol. 61, no. 2, pp. 815-824, 2018.
, “The Rationale and Design of the Reducing Pathology in Alzheimer's Disease through Angiotensin TaRgeting (RADAR) Trial.”, J Alzheimers Dis, vol. 61, no. 2, pp. 803-814, 2018.
, “The Rationale Behind the New Alzheimer's Disease Conceptualization: Lessons Learned During the Last Decades.”, J Alzheimers Dis, vol. 62, no. 3, pp. 1067-1077, 2018.
, “Rats Display Sexual Dimorphism in Phosphorylation of Brain Tau with Age.”, J Alzheimers Dis, vol. 82, no. 2, pp. 855-869, 2021.
, “Rbfox3/NeuN Regulates Alternative Splicing of Tau Exon 10.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1695-1704, 2018.
, “Reaction of Amyloid-β Peptide Antibody with Different Infectious Agents Involved in Alzheimer's Disease.”, J Alzheimers Dis, vol. 63, no. 2, pp. 847-860, 2018.
, “Re-Addressing Dementia by Network Medicine and Mechanism-Based Molecular Endotypes.”, J Alzheimers Dis, vol. 96, no. 1, pp. 47-56, 2023.
, “Real World Recruiting of Older Subjects with Mild Cognitive Impairment for Exercise Trials: Community Readiness is Pivotal.”, J Alzheimers Dis, vol. 62, no. 2, pp. 579-581, 2018.
, “Real-World, Multinational, Retrospective Observational Survey of the ADAS-Cog and Associations with Healthcare Resource Utilization in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 64, no. 3, pp. 899-910, 2018.
, “Reappraisal of Aβ40 and Aβ42 Peptides Measurements in Cerebrospinal Fluid of Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 66, no. 1, pp. 219-227, 2018.
,